U.S. markets closed
  • S&P Futures

    4,261.50
    +6.75 (+0.16%)
     
  • Dow Futures

    34,400.00
    +19.00 (+0.06%)
     
  • Nasdaq Futures

    14,147.25
    +22.50 (+0.16%)
     
  • Russell 2000 Futures

    2,323.70
    +0.10 (+0.00%)
     
  • Crude Oil

    71.05
    +0.17 (+0.24%)
     
  • Gold

    1,864.60
    -1.30 (-0.07%)
     
  • Silver

    27.75
    -0.28 (-1.01%)
     
  • EUR/USD

    1.2129
    +0.0006 (+0.05%)
     
  • 10-Yr Bond

    1.5010
    +0.0390 (+2.67%)
     
  • Vix

    16.39
    +0.74 (+4.73%)
     
  • GBP/USD

    1.4112
    +0.0004 (+0.03%)
     
  • USD/JPY

    110.1000
    +0.0390 (+0.04%)
     
  • BTC-USD

    40,267.81
    +1,291.84 (+3.31%)
     
  • CMC Crypto 200

    1,006.95
    +38.11 (+3.93%)
     
  • FTSE 100

    7,146.68
    +12.62 (+0.18%)
     
  • Nikkei 225

    29,375.94
    +214.14 (+0.73%)
     

Single Shot Of AstraZeneca, Pfizer COVID-19 Vaccines Provide 87% Protection, South Korea Study Shows: Reuters

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • According to real-world data released by South Korea, one dose of COVID-19 vaccines from AstraZeneca Plc (NASDAQ: AZN) and Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ: BNTX) was 86.6% effective in preventing infections among people aged 60 and older, reports Reuters.

  • Data revealed by the Korea Disease Control and Prevention Agency (KDCA) showed the Pfizer/BioNTech shot was 89.7% effective in preventing infection at least two weeks after a first dose was given. In comparison, the AstraZeneca shot was 86.0% effective.

  • The analysis was based on more than 3.5 million people in South Korea aged 60 and older for two months from February 26 and included 521,133 people who received a first dose of either Pfizer or AstraZeneca shot.

  • There were 1,237 COVID-19 cases in the data, and only 29 were from the vaccinated group, the KDCA said.

  • Health ministry official Yoon Tae-ho said the possibility of side effects, including blood clotting, is "extremely low," and they are mostly curable.

  • Price Action: PFE shares are down 0.98% at $39.61, BNTX shares are down 3.48% at $171.22, and AZN shares are up 1.05% at $53.49 during the market trading session on the last check Wednesday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.